Chemistry:Vandortuzumab vedotin

From HandWiki
Revision as of 04:05, 6 February 2024 by Jworkorg (talk | contribs) (add)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Monoclonal antibody
Vandortuzumab vedotin
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetSTEAP1
Clinical data
Other namesRG7450
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6608H10168N1756O2076S44
Molar mass148838.89 g·mol−1

Vandortuzumab vedotin (INN; development code RG7450) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2]

This drug was developed by Genentech/Roche. Development was discontinued in 2017.[3]

References